JUL 31, 2026 · PHASE 2 TRIAL
Premedication to Reduce Amivantamab Associated Infusion Related Reactions
ClinicalTrials.gov
This is an active interventional Phase 2 trial registry record with no results reported; it describes a planned study of premedication strategies to reduce amivantamab infusion reactions in non-small-cell lung cancer.
Reported
Planned enrollment68
PhasePHASE 2
Primary outcome measurePercentage of Participants With Infusion-re…